121 related articles for article (PubMed ID: 26751618)
1. Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers.
Lloret-Linares C; Miyauchi E; Luo H; Labat L; Bouillot JL; Poitou C; Oppert JM; Laplanche JL; Mouly S; Scherrmann JM; Uchida Y; Tachikawa M; Terasaki T; Bergmann JF; Declèves X
Mol Pharm; 2016 Mar; 13(3):766-73. PubMed ID: 26751618
[TBL] [Abstract][Full Text] [Related]
2. Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide.
de Hoogd S; Välitalo PAJ; Dahan A; van Kralingen S; Coughtrie MMW; van Dongen EPA; van Ramshorst B; Knibbe CAJ
Clin Pharmacokinet; 2017 Dec; 56(12):1577-1587. PubMed ID: 28510797
[TBL] [Abstract][Full Text] [Related]
3. Lack of genetic association between OCT1, ABCB1, and UGT2B7 variants and morphine pharmacokinetics.
Nielsen LM; Sverrisdóttir E; Stage TB; Feddersen S; Brøsen K; Christrup LL; Drewes AM; Olesen AE
Eur J Pharm Sci; 2017 Mar; 99():337-342. PubMed ID: 28063968
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver.
Hasegawa Y; Kishimoto S; Shibatani N; Nomura H; Ishii Y; Onishi M; Inotsume N; Takeuchi Y; Fukushima S
J Pharm Pharmacol; 2010 Mar; 62(3):310-4. PubMed ID: 20487213
[TBL] [Abstract][Full Text] [Related]
5. The effect of morbid obesity on morphine glucuronidation.
Lloret-Linares C; Luo H; Rouquette A; Labat L; Poitou C; Tordjman J; Bouillot JL; Mouly S; Scherrmann JM; Bergmann JF; Declèves X
Pharmacol Res; 2017 Apr; 118():64-70. PubMed ID: 27609660
[TBL] [Abstract][Full Text] [Related]
6. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.
Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F
Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559
[TBL] [Abstract][Full Text] [Related]
7. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.
Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ
Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects.
Miyauchi E; Tachikawa M; Declèves X; Uchida Y; Bouillot JL; Poitou C; Oppert JM; Mouly S; Bergmann JF; Terasaki T; Scherrmann JM; Lloret-Linares C
Mol Pharm; 2016 Aug; 13(8):2631-40. PubMed ID: 27347605
[TBL] [Abstract][Full Text] [Related]
9. Morphine and metabolites plasma levels after administration of sustained release morphine in Roux-en-Y gastric bypass subjects versus matched control subjects.
Hachon L; Reis R; Labat L; Poitou C; Jacob A; Declèves X; Lloret-Linares C
Surg Obes Relat Dis; 2017 Nov; 13(11):1869-1874. PubMed ID: 28864105
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach.
Lloret-Linares C; Hirt D; Bardin C; Bouillot JL; Oppert JM; Poitou C; Chast F; Mouly S; Scherrmann JM; Bergmann JF; Declèves X
Clin Pharmacokinet; 2014 Oct; 53(10):919-30. PubMed ID: 25141973
[TBL] [Abstract][Full Text] [Related]
11. Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population.
Lloret Linares C; Hajj A; Poitou C; Simoneau G; Clement K; Laplanche JL; Lépine JP; Bergmann JF; Mouly S; Peoc'h K
Obes Surg; 2011 Aug; 21(8):1257-64. PubMed ID: 20411349
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain.
De Gregori S; Minella CE; De Gregori M; Tinelli C; Ranzani GN; Govoni S; Allegri M; Regazzi M
Ther Drug Monit; 2014 Jun; 36(3):335-44. PubMed ID: 24595069
[TBL] [Abstract][Full Text] [Related]
13. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.
Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F
Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580
[TBL] [Abstract][Full Text] [Related]
14. Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney.
Li CY; Basit A; Gupta A; Gáborik Z; Kis E; Prasad B
J Steroid Biochem Mol Biol; 2019 Jul; 191():105350. PubMed ID: 30959153
[TBL] [Abstract][Full Text] [Related]
15. Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption.
Bastami S; Gupta A; Zackrisson AL; Ahlner J; Osman A; Uppugunduri S
Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):423-31. PubMed ID: 24703092
[TBL] [Abstract][Full Text] [Related]
16. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
[TBL] [Abstract][Full Text] [Related]
17. Environmental and genetic factors associated with morphine response in the postoperative period.
Coulbault L; Beaussier M; Verstuyft C; Weickmans H; Dubert L; Trégouet D; Descot C; Parc Y; Lienhart A; Jaillon P; Becquemont L
Clin Pharmacol Ther; 2006 Apr; 79(4):316-24. PubMed ID: 16580900
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of MRP2, MRP3 and UGT2B1 in the liver affects the disposition of morphine and its glucuronide conjugate in a rat model of cholestasis.
Hasegawa Y; Kishimoto S; Takahashi H; Inotsume N; Takeuchi Y; Fukushima S
J Pharm Pharmacol; 2009 Sep; 61(9):1205-10. PubMed ID: 19703370
[TBL] [Abstract][Full Text] [Related]
20. ABCC3 genetic variants are associated with postoperative morphine-induced respiratory depression and morphine pharmacokinetics in children.
Chidambaran V; Venkatasubramanian R; Zhang X; Martin LJ; Niu J; Mizuno T; Fukuda T; Meller J; Vinks AA; Sadhasivam S
Pharmacogenomics J; 2017 Mar; 17(2):162-169. PubMed ID: 26810133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
